# Early Versus Late Caffeine for ELBW Newborns

> **NCT02524249** · NA · TERMINATED · sponsor: **Wayne State University** · enrollment: 110 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia
- Apnea of Prematurity

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Placebo (dextrose)

## Key facts

- **NCT ID:** NCT02524249
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 110 (ACTUAL)
- **Why stopped:** Frequent protocol violations
- **Last updated:** 2022-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524249, "Early Versus Late Caffeine for ELBW Newborns". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02524249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*